DBTX Annual CFO
-$56.90 M
-$13.75 M-31.86%
31 December 2022
Summary:
As of February 5, 2025, DBTX annual cash flow from operations is -$56.90 million, with the most recent change of -$13.75 million (-31.86%) on December 31, 2022. During the last 3 years, it has fallen by -$7.49 million (-15.15%).DBTX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DBTX Quarterly CFO
-$10.27 M
+$6.79 M+39.80%
30 June 2023
Summary:
As of February 5, 2025, DBTX quarterly cash flow from operations is -$10.27 million, with the most recent change of +$6.79 million (+39.80%) on June 30, 2023. Over the past year, it has increased by +$3.14 million (+23.42%).DBTX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DBTX TTM CFO
-$48.81 M
+$3.14 M+6.04%
30 June 2023
Summary:
As of February 5, 2025, DBTX TTM cash flow from operations is -$48.81 million, with the most recent change of +$3.14 million (+6.04%) on June 30, 2023. Over the past year, it has increased by +$7.80 million (+13.78%).DBTX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DBTX Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -31.9% | +23.4% | +13.8% |
| 3 y3 years | -15.2% | -29.6% | -146.1% |
| 5 y5 years | -57.7% | - | - |
DBTX Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | +74.2% | +99.4% | +309.9% |
Decibel Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | -$10.27 M(-39.8%) | -$48.81 M(-6.0%) |
| Mar 2023 | - | -$17.06 M(+119.6%) | -$51.95 M(-8.7%) |
| Dec 2022 | -$56.90 M(+31.9%) | -$7.77 M(-43.4%) | -$56.90 M(-3.0%) |
| Sept 2022 | - | -$13.72 M(+2.3%) | -$58.68 M(+3.7%) |
| June 2022 | - | -$13.41 M(-39.1%) | -$56.61 M(+15.9%) |
| Mar 2022 | - | -$22.01 M(+130.6%) | -$48.85 M(+13.2%) |
| Dec 2021 | -$43.15 M | -$9.54 M(-18.1%) | -$43.15 M(+11.3%) |
| Sept 2021 | - | -$11.65 M(+106.2%) | -$38.75 M(+11.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2021 | - | -$5.65 M(-65.4%) | -$34.79 M(-6.1%) |
| Mar 2021 | - | -$16.31 M(+216.7%) | -$37.06 M(+13.5%) |
| Dec 2020 | -$32.66 M(-33.9%) | -$5.15 M(-33.0%) | -$32.66 M(+18.7%) |
| Sept 2020 | - | -$7.68 M(-3.1%) | -$27.51 M(+38.7%) |
| June 2020 | - | -$7.92 M(-33.4%) | -$19.83 M(+66.6%) |
| Mar 2020 | - | -$11.91 M | -$11.91 M |
| Dec 2019 | -$49.41 M(+36.9%) | - | - |
| Dec 2018 | -$36.08 M | - | - |
FAQ
- What is Decibel Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Decibel Therapeutics?
- What is Decibel Therapeutics annual CFO year-on-year change?
- What is Decibel Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Decibel Therapeutics?
- What is Decibel Therapeutics quarterly CFO year-on-year change?
- What is Decibel Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Decibel Therapeutics?
- What is Decibel Therapeutics TTM CFO year-on-year change?
What is Decibel Therapeutics annual cash flow from operations?
The current annual CFO of DBTX is -$56.90 M
What is the all time high annual CFO for Decibel Therapeutics?
Decibel Therapeutics all-time high annual cash flow from operations is -$32.66 M
What is Decibel Therapeutics annual CFO year-on-year change?
Over the past year, DBTX annual cash flow from operations has changed by -$13.75 M (-31.86%)
What is Decibel Therapeutics quarterly cash flow from operations?
The current quarterly CFO of DBTX is -$10.27 M
What is the all time high quarterly CFO for Decibel Therapeutics?
Decibel Therapeutics all-time high quarterly cash flow from operations is -$5.15 M
What is Decibel Therapeutics quarterly CFO year-on-year change?
Over the past year, DBTX quarterly cash flow from operations has changed by +$3.14 M (+23.42%)
What is Decibel Therapeutics TTM cash flow from operations?
The current TTM CFO of DBTX is -$48.81 M
What is the all time high TTM CFO for Decibel Therapeutics?
Decibel Therapeutics all-time high TTM cash flow from operations is -$11.91 M
What is Decibel Therapeutics TTM CFO year-on-year change?
Over the past year, DBTX TTM cash flow from operations has changed by +$7.80 M (+13.78%)